Table 1 Baseline characteristics and procedure characteristics before and after matching on the propensity score.

From: Single-cell and bulk transcriptomics uncovers PRKD2-driven tumor stemness and progression in multiple myeloma

 

Before matching

After matching

Variables

Total (n = 132)

CR or PR (n = 25)

RR (n = 58)

NDMM (n = 49)

p-value

Total (n = 24)

CR or PR (n = 7)

RR (n = 8)

NDMM (n = 9)

p-value

Gender, n (%)

    

0.763

    

0.201

Female

61 (46)

10 (40)

27 (47)

24 (49)

 

8 (33)

3 (43)

4 (50)

1 (11)

 

Male

71 (54)

15 (60)

31 (53)

25 (51)

 

16 (67)

4 (57)

4 (50)

8 (89)

 

Age, n (%)

    

0.018

    

0.051

< 65

79 (60)

19 (76)

38 (66)

22 (45)

 

12 (50)

6 (86)

4 (50)

2 (22)

 

≥ 65

53 (40)

6 (24)

20 (34)

27 (55)

 

12 (50)

1 (14)

4 (50)

7 (78)

 

ISS stage, n (%)

    

0.001

    

0.052

I

39 (30)

8 (32)

13 (22)

18 (37)

 

9 (38)

5 (71)

1 (12)

3 (33)

 

II

45 (34)

9 (36)

19 (33)

17 (35)

 

6 (25)

0 (0)

5 (62)

1 (11)

 

III

41 (31)

8 (32)

26 (45)

7 (14)

 

3 (12)

1 (14)

1 (12)

1 (11)

 

Other

7 (5)

0 (0)

0 (0)

7 (14)

 

6 (25)

1 (14)

1 (12)

4 (44)

 
  1. IQR, interquartile range; CR, Complete remission; PR, Partial remission; RR, Refractory/relapsed; NDMM, Initial diagnosis multiple myeloma.
Back to article page